AXT posted lower revenues and gross profit for Q2. Permit delays for gallium arsenide exports caused the decrease. Q3 2025 results are also expected to be weaker.
AXT, Inc. (NASDAQ:AXTI ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Gary L. Fischer - CFO, VP & Corporate Secretary Leslie Green - Investor Relations Morris S.
FREMONT, Calif.--(BUSINESS WIRE)--AXT, Inc. (NasdaqGS: AXTI), a leading manufacturer of compound semiconductor wafer substrates, today reported financial results for the second quarter, ended June 30, 2025. Management Qualitative Comments “Our substrate revenue increased in Q2 from the prior quarter, though the increase was less than we had expected as a result of longer processing times for ga...
FREMONT, Calif.--(BUSINESS WIRE)--AXT, Inc. (NasdaqGS: AXTI), a leading manufacturer of compound semiconductor substrates, is saddened to report that Ms. Christine Russell, a member of the Company's Board of Directors, passed away on July 11, 2025. Ms. Russell joined the Company's Board in December 2019 as an independent director. Ms. Russell served as Chair of the Audit Committee and was a mem...
AXT reported poor financial performance for Q1 2025 with negative profit margins. The company is still dealing with Chinese prohibitions on indium phosphide exports. AXT downgraded its own revenue expectations for Q2 2025.
FREMONT, Calif.--(BUSINESS WIRE)--AXT, Inc. (NasdaqGS: AXTI), a leading manufacturer of compound semiconductor substrates, today announced a preliminary revenue range for its second quarter, ended June 30, 2025. AXT's full financial results for the second quarter of 2025 are scheduled to be announced on July 31, 2025. AXT expects preliminary revenue for the second quarter of 2025 to be in the r...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.